Prevalence of poor medication adherence before and after retirement using alternative definitions of poor adherence
| Days covered by treatment, % | Poor adherence, % | Adjusted* OR (95% CI) | |
|---|---|---|---|
| Before retirement | After retirement | ||
| Men | |||
| Antihypertensive medication | |||
| < 20 | 3.0 | 4.4 | 1.50 (1.09–2.07) |
| < 30 | 3.9 | 5.4 | 1.40 (1.06–1.83) |
| < 40 | 5.6 | 7.2 | 1.32 (1.03–1.68) |
| < 50 | 8.2 | 10.6 | 1.34 (1.10–1.64) |
| < 60 | 12.0 | 14.5 | 1.26 (1.05–1.50) |
| < 70 | 15.5 | 19.0 | 1.29 (1.09–1.52) |
| < 80 | 19.9 | 24.1 | 1.29 (1.11–1.49) |
| Antidiabetic medication | |||
| < 20 | 0.9 | 2.5 | 2.74 (1.18–6.37) |
| < 30 | 1.4 | 4.4 | 3.45 (1.92–6.18) |
| < 40 | 2.3 | 5.2 | 2.40 (1.37–4.20) |
| < 50 | 3.9 | 7.0 | 1.88 (1.03–3.44) |
| < 60 | 6.4 | 9.3 | 1.52 (0.83–2.76) |
| < 70 | 9.7 | 12.9 | 1.38 (0.87–2.19) |
| < 80 | 15.5 | 19.0 | 1.29 (0.86–1.92) |
| Women | |||
| Antihypertensive medication | |||
| < 20 | 2.7 | 3.9 | 1.48 (1.20–1.84) |
| < 30 | 4.2 | 5.8 | 1.40 (1.18–1.67) |
| < 40 | 6.1 | 7.5 | 1.25 (1.07–1.46) |
| < 50 | 9.7 | 11.2 | 1.17 (1.03–1.33) |
| < 60 | 14.0 | 15.7 | 1.15 (1.03–1.28) |
| < 70 | 18.9 | 20.7 | 1.12 (1.02–1.24) |
| < 80 | 23.8 | 25.5 | 1.10 (1.00–1.20) |
| Antidiabetic medication | |||
| < 20 | 1.9 | 2.0 | 1.03 (0.39–2.69) |
| < 30 | 3.1 | 3.0 | 0.97 (0.44–2.12) |
| < 40 | 3.8 | 4.2 | 1.11 (0.62–1.98) |
| < 50 | 6.1 | 5.9 | 0.97 (0.57–1.68) |
| < 60 | 10.0 | 9.2 | 0.92 (0.58–1.46) |
| < 70 | 13.8 | 11.8 | 0.85 (0.57–1.27) |
| < 80 | 20.1 | 16.6 | 0.80 (0.56–1.14) |
Note: CI = confidence interval, OR = odds ratio.
↵* Odds ratio for poor adherence 1–4 years after retirement compared with 1–3 years before retirement derived from repeated-measures logistic regression generalized estimating equations adjusted for sex, age at retirement and calendar year.